Huntsman Corporation (HUN)
HUN (NYSE:Chemicals)
$19.71

-0.08
-0.40%
Today's Range: 19.69 - 19.96 |
HUN Avg Daily Volume: 4,241,600
| Last Update: 05/21/13 - 4:04 PM EDT |
| Volume: 2,209,284 |
| YTD Performance: 23.96%
|
| Open: $19.77 |
| Previous Close: $19.79 |
| 52 Week Range: $10.98 -
$20.14 |
| Oustanding Shares: 241,144,776 |
| Market Cap: 4,772,255,117 |
6-Month Chart
TheStreet Ratings Grade for HUN
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
1 |
1 |
1 |
1 |
| Moderate Buy |
0 |
0 |
0 |
0 |
| Hold |
7 |
7 |
7 |
7 |
| Moderate Sell |
0 |
0 |
0 |
0 |
| Strong Sell |
1 |
1 |
1 |
1 |
| Mean Rec. |
3.00 |
3.00 |
3.00 |
3.00 |
| Latest Dividend: |
0.13 |
| Latest Dividend Yield: |
2.53% |
| Dividend Ex-Date: |
06/12/13 |
| Price Earnings Ratio: |
26.74 |
|
| Price Earnings Comparisons: |
| HUN |
Sector Avg. |
S&P 500 |
| 26.74 |
27.10 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
20.11%
|
50.46%
|
119.00%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
-0.30 |
0.44 |
0.13 |
| Net Income |
48.40 |
2.29 |
0.48 |
| EPS |
49.50 |
2.12 |
0.46 |
| Earnings for HUN: |
| EBITDA |
1.36B |
| Revenue |
11.19B |
|
Average Earnings Estimates
;Qtr (09/13);FY (12/13);FY (12/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (12/12);FY (12/13)) |
|
| Average Estimate |
$0.44 |
$0.59 |
$1.68 |
$2.22 |
| Number of Analysts |
8 |
7 |
10 |
9 |
| High Estimate |
$0.50 |
$0.66 |
$1.88 |
$2.60 |
| Low Estimate |
$0.36 |
$0.54 |
$1.55 |
$2.00 |
| Prior Year |
$0.58 |
$0.70 |
$2.25 |
$1.68 |
| Growth Rate (Year over Year) |
-24.78% |
-15.10% |
-25.29% |
32.33% |
| Feb 03, 2013 | 1:00 PM EST
One hedge fund has taken sizable stakes in these names, so let’s take a closer look.
Jan 14, 2013 | 8:41 AM EST
Shares of HUN downgraded to Market Perform from Overweight, Wells Fargo said. $17-$19 price target. Valuation call.
Jan 10, 2013 | 8:28 AM EST
HUN was downgraded to Neutral from Buy, UBS said. $18 price target. Recent price appreciation increases above our valuation.
Jan 03, 2013 | 8:30 AM EST
HUN was upgraded to Buy, Citigroup said. Company is leveraged to lower TiO2 prices.
Dec 03, 2012 | 7:57 AM EST
HUN estimates lowered through 2013, UBS said. Softer 4Q expected by company. Buy rating and $16 price target.
Nov 05, 2012 | 8:27 AM EST
Shares of HUN now seen reaching $18, Jefferies said. Estimates also raised on solid third quarter. Hold rating.
Nov 05, 2012 | 8:22 AM EST
HUN was upgraded to Overweight from Neutral, Piper Jaffray said. $21 price target. Polyurethanes are just getting started.
Sep 18, 2012 | 8:21 AM EDT
Shares of HUN now seen reaching $16, Jefferies said. Estimates also raised on cost- cutting tailwinds. Hold rating.
Jun 18, 2012 | 6:51 AM EDT
HUN was downgraded from Buy to Hold, Keybanc said. Company is exposed to slower growth in Europe and China.
| Jun 15, 2012 | 2:30 PM EDT
The current environment appears target rich for mergers and private equity acquisitions.